Annual Net Margin
30.14%
-5.50%-15.43%
31 December 2023
Summary:
Regeneron Pharmaceuticals annual net profit margin is currently 30.14%, with the most recent change of -5.50% (-15.43%) on 31 December 2023. During the last 3 years, it has fallen by -11.21% (-27.11%). REGN annual net margin is now -44.63% below its all-time high of 54.43%, reached on 31 December 2012.REGN Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
36.03%
-4.35%-10.77%
30 September 2024
Summary:
Regeneron Pharmaceuticals quarterly net profit margin is currently 36.03%, with the most recent change of -4.35% (-10.77%) on 30 September 2024. Over the past year, it has increased by +6.06% (+20.22%). REGN quarterly net margin is now -40.26% below its all-time high of 60.31%, reached on 30 June 2021.REGN Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN Net Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -15.4% | +20.2% |
3 y3 years | -27.1% | -23.8% |
5 y5 years | -36.5% | -6.2% |
REGN Net Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -40.0% | at low | -23.8% | +56.9% |
5 y | 5 years | -40.0% | at low | -40.3% | +56.9% |
alltime | all time | -44.6% | +105.3% | -40.3% | +105.0% |
Regeneron Pharmaceuticals Net Margin History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | 36.03%(-10.8%) |
June 2024 | - | 40.38%(+75.9%) |
Mar 2024 | - | 22.96%(-32.0%) |
Dec 2023 | 30.14%(-15.4%) | 33.77%(+12.7%) |
Sept 2023 | - | 29.97%(-2.3%) |
June 2023 | - | 30.66%(+18.6%) |
Mar 2023 | - | 25.86%(-26.2%) |
Dec 2022 | 35.64%(-29.1%) | 35.06%(-21.8%) |
Sept 2022 | - | 44.81%(+50.3%) |
June 2022 | - | 29.82%(-9.2%) |
Mar 2022 | - | 32.83%(-27.1%) |
Dec 2021 | 50.25%(+21.5%) | 45.01%(-4.8%) |
Sept 2021 | - | 47.27%(-21.6%) |
June 2021 | - | 60.31%(+36.8%) |
Mar 2021 | - | 44.10%(-7.0%) |
Dec 2020 | 41.35%(+28.2%) | 47.43%(+29.2%) |
Sept 2020 | - | 36.71%(-20.1%) |
June 2020 | - | 45.97%(+34.6%) |
Mar 2020 | - | 34.16%(-19.6%) |
Dec 2019 | 32.26%(-32.1%) | 42.50%(+10.7%) |
Sept 2019 | - | 38.40%(+213.7%) |
June 2019 | - | 12.24%(-63.6%) |
Mar 2019 | - | 33.59%(-6.0%) |
Dec 2018 | 47.50%(+132.7%) | - |
Sept 2018 | - | 35.75%(+4.3%) |
June 2018 | - | 34.29%(+8.4%) |
Mar 2018 | - | 31.62%(+188.5%) |
Dec 2017 | 20.41%(+10.8%) | 10.96%(-57.7%) |
Sept 2017 | - | 25.88%(-1.9%) |
June 2017 | - | 26.38%(+39.8%) |
Mar 2017 | - | 18.87%(-8.5%) |
Dec 2016 | 18.42%(+18.8%) | 20.63%(-4.9%) |
Sept 2016 | - | 21.70%(+34.1%) |
June 2016 | - | 16.18%(+7.2%) |
Mar 2016 | - | 15.10%(+6.9%) |
Dec 2015 | 15.50%(+29.3%) | 14.12%(-23.7%) |
Sept 2015 | - | 18.50%(-5.1%) |
June 2015 | - | 19.49%(+123.0%) |
Mar 2015 | - | 8.74%(-22.2%) |
Dec 2014 | 11.99%(-39.0%) | 11.23%(-2.3%) |
Sept 2014 | - | 11.49%(-20.6%) |
June 2014 | - | 14.47%(+32.5%) |
Mar 2014 | - | 10.92%(-22.7%) |
Dec 2013 | 19.66%(-63.9%) | 14.12%(-40.3%) |
Sept 2013 | - | 23.67%(+24.0%) |
June 2013 | - | 19.09%(-15.1%) |
Mar 2013 | - | 22.49%(-49.8%) |
Dec 2012 | 54.43%(-209.4%) | - |
Sept 2012 | - | 44.77%(+77.6%) |
June 2012 | - | 25.21%(+401.2%) |
Mar 2012 | - | 5.03%(-111.6%) |
Dec 2011 | -49.74%(+118.5%) | -43.46%(-28.3%) |
Sept 2011 | - | -60.65%(+4.6%) |
June 2011 | - | -57.98%(+49.7%) |
Mar 2011 | - | -38.72%(+254.6%) |
Dec 2010 | -22.76%(+27.3%) | -10.92%(-65.8%) |
Sept 2010 | - | -31.96%(+45.4%) |
June 2010 | - | -21.98%(-25.4%) |
Mar 2010 | - | -29.48%(-21.8%) |
Dec 2009 | -17.88%(-46.1%) | -37.70%(+4283.7%) |
Sept 2009 | - | -0.86%(-94.8%) |
June 2009 | - | -16.59%(-19.2%) |
Mar 2009 | - | -20.52%(-59.0%) |
Dec 2008 | -33.18%(-60.7%) | -50.03%(+55.4%) |
Sept 2008 | - | -32.20%(+4.5%) |
June 2008 | - | -30.81%(+49.5%) |
Mar 2008 | - | -20.61%(+2.1%) |
Dec 2007 | -84.46% | -20.19%(-87.4%) |
Sept 2007 | - | -160.63%(+33.2%) |
Date | Annual | Quarterly |
---|---|---|
June 2007 | - | -120.63%(-36.3%) |
Mar 2007 | - | -189.49%(-36.7%) |
Dec 2006 | -161.30%(+11.9%) | -299.35%(+70.6%) |
Sept 2006 | - | -175.44%(+43.3%) |
June 2006 | - | -122.42%(+9.4%) |
Mar 2006 | - | -111.86%(-34.3%) |
Dec 2005 | -144.19%(-701.8%) | -170.29%(-20.4%) |
Sept 2005 | - | -213.98%(+29.7%) |
June 2005 | - | -164.97%(+548.5%) |
Mar 2005 | - | -25.44%(-529.0%) |
Dec 2004 | 23.96%(-112.8%) | 5.93%(-119.6%) |
Sept 2004 | - | -30.33%(-40.8%) |
June 2004 | - | -51.20%(-43.8%) |
Dec 2003 | -186.89%(-67.0%) | -91.09%(-42.2%) |
Sept 2003 | - | -157.54%(-53.8%) |
June 2003 | - | -340.82%(+14.7%) |
Mar 2003 | - | -297.06%(-59.1%) |
Dec 2002 | -565.66%(+63.2%) | -726.65%(+45.4%) |
Sept 2002 | - | -499.79%(-8.5%) |
June 2002 | - | -546.29%(+6.1%) |
Mar 2002 | - | -514.98%(-20.1%) |
Dec 2001 | -346.70%(+785.3%) | -644.81%(+77.3%) |
Sept 2001 | - | -363.70%(+41.7%) |
June 2001 | - | -256.69%(+24.3%) |
Mar 2001 | - | -206.51%(+367.4%) |
Dec 2000 | -39.16%(-41.5%) | -44.18%(+112.5%) |
Sept 2000 | - | -20.79%(+6.0%) |
June 2000 | - | -19.62%(-71.9%) |
Mar 2000 | - | -69.71%(+492.8%) |
Dec 1999 | -66.96%(+198.3%) | -11.76%(-72.9%) |
Sept 1999 | - | -43.36%(-67.2%) |
June 1999 | - | -132.20%(-19.8%) |
Mar 1999 | - | -164.81%(+127.7%) |
Dec 1998 | -22.45%(-47.9%) | -72.37%(+458.4%) |
Sept 1998 | - | -12.96%(-183.3%) |
June 1998 | - | 15.56%(-126.6%) |
Mar 1998 | - | -58.46%(-707.7%) |
Dec 1997 | -43.12%(-67.9%) | 9.62%(-145.1%) |
Sept 1997 | - | -21.35%(-67.2%) |
June 1997 | - | -65.15%(-31.5%) |
Mar 1997 | - | -95.16%(-23.6%) |
Dec 1996 | -134.44%(+56.7%) | -124.62%(-13.2%) |
Sept 1996 | - | -143.55%(+17.1%) |
June 1996 | - | -122.58%(-18.3%) |
Mar 1996 | - | -150.00%(+11.5%) |
Dec 1995 | -85.77%(-35.2%) | -134.48%(+17.4%) |
Sept 1995 | - | -114.52%(+97.8%) |
June 1995 | - | -57.89%(-4.9%) |
Mar 1995 | - | -60.87%(-19.2%) |
Dec 1994 | -132.33%(-64.8%) | -75.32%(+67.6%) |
Sept 1994 | - | -44.94%(-84.1%) |
June 1994 | - | -283.33%(-20.6%) |
Mar 1994 | - | -356.67%(-10.1%) |
Dec 1993 | -376.42%(+126.6%) | -396.55%(+48.7%) |
Sept 1993 | - | -266.67%(-63.1%) |
June 1993 | - | -723.08%(+63.3%) |
Mar 1993 | - | -442.86%(+59.2%) |
Dec 1992 | -166.09%(+169.5%) | -278.26%(+15.1%) |
Sept 1992 | - | -241.67%(+109.0%) |
June 1992 | - | -115.63%(+22.6%) |
Mar 1992 | - | -94.29%(-10.2%) |
Dec 1991 | -61.64%(-6.6%) | -105.00%(+121.7%) |
Sept 1991 | - | -47.37%(+168.4%) |
June 1991 | - | -17.65%(-67.9%) |
Mar 1991 | - | -55.00%(-20.6%) |
Dec 1990 | -66.00% | -69.23%(+12.5%) |
Sept 1990 | - | -61.54%(-7.7%) |
June 1990 | - | -66.67%(0.0%) |
Mar 1990 | - | -66.67% |
FAQ
- What is Regeneron Pharmaceuticals annual net profit margin?
- What is the all time high annual net margin for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual net margin year-on-year change?
- What is Regeneron Pharmaceuticals quarterly net profit margin?
- What is the all time high quarterly net margin for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly net margin year-on-year change?
What is Regeneron Pharmaceuticals annual net profit margin?
The current annual net margin of REGN is 30.14%
What is the all time high annual net margin for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual net profit margin is 54.43%
What is Regeneron Pharmaceuticals annual net margin year-on-year change?
Over the past year, REGN annual net profit margin has changed by -5.50% (-15.43%)
What is Regeneron Pharmaceuticals quarterly net profit margin?
The current quarterly net margin of REGN is 36.03%
What is the all time high quarterly net margin for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly net profit margin is 60.31%
What is Regeneron Pharmaceuticals quarterly net margin year-on-year change?
Over the past year, REGN quarterly net profit margin has changed by +6.06% (+20.22%)